Eva Gonzalez Suarez (Eva Gonzalez-Suarez, Eva González-Suárez, E González-Suárez)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Locally Advanced

Squamous Cell Carcinoma

Postmenopausal Women

Mesenchymal Stem Cells

Top Venues

Nature communications

EMBO molecular medicine

Journal of mammary gland biology and neoplasia

This page only lists publications with an associated author ORCID identifier.

Publications

Laura Lorenzo-Sanz, Marta Lopez-Cerda, Victoria da Silva-Diz, Marta H Artés, Sandra Llop, Rosa M Penin, Josep Oriol Bermejo, Eva Gonzalez Suarez, Manel Esteller, Francesc Viñals, Enrique Espinosa, Marc Oliva, Josep Maria Piulats, Juan Martin-Liberal, Purificación Muñoz
Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma. Nature communications 15 (1) (2024)
Laura Lorenzo-Sanz, Marta Lopez-Cerda, Victoria da Silva-Diz, Marta H Artés, Sandra Llop, Rosa M Penin, Josep Oriol Bermejo, Eva Gonzalez Suarez, Manel Esteller, Francesc Viñals, Enrique Espinosa, Marc Oliva, Josep Maria Piulats, Juan Martin-Liberal, Purificación Muñoz
Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma. Nature communications 15 (1) (2024)
Laura Lorenzo-Sanz, Marta Lopez-Cerda, Victoria da Silva-Diz, Marta H Artés, Sandra Llop, Rosa M Penin, Josep Oriol Bermejo, Eva Gonzalez Suarez, Manel Esteller, Francesc Viñals, Enrique Espinosa, Marc Oliva, Josep Maria Piulats, Juan Martin-Liberal, Purificación Muñoz
Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma. Nature communications 15 (1) (2024)
Renee van Amerongen, Mohamed Bentires-Alj, Antonius L van Boxtel, Robert B Clarke, Silvia Fre, Eva Gonzalez Suarez, Richard Iggo, Martin Jechlinger, Jos Jonkers, Marja L Mikkola, Zuzana Sumbalova Koledova, Therese Sørlie, Maria D M Vivanco
Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer research. Journal of mammary gland biology and neoplasia 28 (1) (2023)
Ana Sofia Rocha, Alejandro Collado-Solé, Osvaldo Graña-Castro, Jaime Redondo-Pedraza, Gonzalo Soria-Alcaide, Alex Cordero, Patricia G Santamaría, Eva Gonzalez Suarez
Luminal Rank loss decreases cell fitness leading to basal cell bipotency in parous mammary glands. Nature communications 14 (1) (2023)
Marina Ciscar, Eva María Trinidad, Gema Perez-Chacon, Mansour A Alsaleem, Maria Jimenez, Maria J Jimenez-Santos, Hector Perez-Montoyo, Adrián Sanz-Moreno, Andrea Vethencourt, Michael S Toss, Anna Petit, Maria T Soler-Monso, Victor Lopez, Jorge Gómez-Miragaya, Clara Gomez-Aleza, Lacey Elizabeth Dobrolecki, Michael T Lewis, Alejandra Bruna, Silvana Mouron, Miguel Quintela-Fandino, Fatima Al-Shahrour, Antonio Martinez-Aranda, Angels Sierra, Andrew R Green, Emad Rakha, Eva Gonzalez Suarez
RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancer. EMBO molecular medicine (2023)
Clara Gómez-Aleza, Eva Gonzalez Suarez
Inhibition of RANK signaling as a potential immunotherapy in breast cancer. Oncoimmunology 10 (1) (2021)
Clara Gómez-Aleza, Bastien Nguyen, Guillermo Yoldi, Marina Ciscar, Alexandra Barranco, Enrique Hernández-Jiménez, Marion Maetens, Roberto Salgado, Maria Zafeiroglou, Pasquale Pellegrini, David Venet, Soizic Garaud, Eva María Trinidad, Sandra Benítez, Peter Vuylsteke, Laura Polastro, Hans P M W Wildiers, Philippe Simon, Geoffrey J Lindeman, Denis Larsimont, Gert Van den Eynden, Chloé Velghe, Françoise Rothé, Karen Willard-Gallo, Stefan Michiels, Purificación Muñoz, Thierry Walzer, Lourdes Planelles, Josef Penninger, Hatem A Azim, Sherene Loi, Martine Piccart, Christos Sotiriou, Eva Gonzalez Suarez
Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells. Nature communications 11 (1) (2020)